Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.26  0.07  3.00%   
About 61% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
six days ago at kalkinemedia.com         
Why Has Arcus Biosciences Seen A Sharp Share Price Decline?
news
six days ago at gurufocus.com         
Lisata Therapeutics to Present at the Investival Showcase USA
Gurufocus Stories at Macroaxis
six days ago at gurufocus.com         
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended ...
Gurufocus Stories at Macroaxis
six days ago at seekingalpha.com         
Solid Biosciences GAAP EPS of -1.00 misses by 0.20
seekingalpha News
six days ago at simplywall.st         
Neurocrine Biosciences Begins Phase 1 Study Of New VMAT2 Inhibitor For Neurological Conditions
Simply Wall St News at Macroaxis
over a week ago at gurufocus.com         
Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI ...
Gurufocus Stories at Macroaxis
over a week ago at insidermonkey.com         
IDEAYA Biosciences, Inc. Partners with ATTMOS for AI-Driven Drug Discovery Platform
insidermonkey News
over a week ago at gurufocus.com         
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBI-1140675, a ...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to De...
Yahoo News
over a week ago at bizjournals.com         
Colossal Biosciences reveals mice with woolly mammoth traits
bizjournals News
over a week ago at businesswire.com         
Parse Biosciences prvoit de lancer des produits daccessibilit de la chromatine pour les cellules uni...
businesswire News
over a week ago at simplywall.st         
Is Hester Biosciences A Risky Investment?
Simply Wall St News at Macroaxis
over a week ago at globenewswire.com         
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635
Macroaxis News: globenewswire.com
over a week ago at businesswire.com         
Parse Biosciences adianta planos para lanar produtos de acessibilidade cromatina de clula nica
businesswire News
over a week ago at simplywall.st         
Shenzhen Chipscreen Biosciences Full Year 2024 Earnings Misses Expectations
Simply Wall St News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance